Clinical trial
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
NCT05498181 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 11, 2022
- Completion date
- January 31, 2026
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodialysis